News in the Life Sciences Industry

DAVENPORT, Fla., Oct. 11, 2019 /PRNewswire/ -- Marizyme, Inc. ("Marizyme" or the "Company"), a publicly traded (OTC:MRZM) company focused on acquiring late-stage drug assets to develop for use in the acute care space, announced today that they have agreed to exclusively distribute Somahlution's... Read more ››

NEW YORK, Oct. 11, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that on October 2, 2019, the Board of Directors of Spherix Incorporated ("Spherix") approved a distribution to Spherix stockholders of 100,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by Spherix.

SILVER SPRING, Md., Oct. 11, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow is not indicated... Read more ››

BALTIMORE, Oct. 11, 2019 /PRNewswire/ -- The African American Neuroscience Research Initiative (AANRI) announced today the receipt of a $275,000 grant from the Abell Foundation, which will provide critical funds to support the development and growth of the collaboration between the African American... Read more ››

SAN RAMON, Calif., Oct. 11, 2019 /PRNewswire/ -- Surprising results in a new national survey find that consumers rarely trust popular celebrity endorsements for weight loss programs. In fact, according to the survey, conducted by LeanMD, Inc., nearly 60% of adults say medical professionals are... Read more ››

OAKLAND, Calif., Oct. 11, 2019 /PRNewswire/ -- Kaiser Permanente is again among the nation's best for providing safe and effective care and exceptional service to its Medicare members. According to the Read more ››

ALBANY, N.Y., Oct. 11, 2019 /PRNewswire/ -- Glauconix Biosciences, Inc., a specialty pharmaceutical company that uses its patented platform technology to develop human 3D ocular tissues that mimic the fluid dynamics in the eye to expedite and de-risk the R&D of ophthalmic treatments, announced... Read more ››

FREMONT, Calif., Oct. 11, 2019 /PRNewswire/ -- Q'Apel Medical announced today that industry veteran King Nelson is joining the company as CEO. Nelson brings more than three decades of experience as a medical device executive and has extensive background in new product development, marketing and... Read more ››

DUBLIN, Oct. 11, 2019 /PRNewswire/ -- The Read more ››

INDIANAPOLIS, Oct. 11, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved REYVOW(TM) (lasmiditan) an oral medication for the acute treatment of migraine, with or without aura, in adults. REYVOW has a unique mechanism... Read more ››

LOS ANGELES, Oct. 11, 2019 /PRNewswire/ -- Turn Therapeutics(TM), Inc., a Los Angeles-based pharmaceutical and medical device company, has announced FDA clearance of Protego(TM) Antimicrobial Wound Dressing, an important and disruptive innovation to traditional petroleum saturated gauze dressings.... Read more ››

DUBLIN, Oct. 11, 2019 /PRNewswire/ -- The Read more ››

CLEARWATER, Fla., Oct. 11, 2019 /PRNewswire/ -- WestCMR, the world's leading healthcare industry surplus surgical supply company, is proud to celebrate supply chain professionals, during National Health Care Supply Chain Week (SC Week) October 6-12, for the important role they... Read more ››